Log in to save to my catalogue

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral...

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8346248

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

About this item

Full title

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

Author / Creator

Com-COV Study Group , Liu, Xinxue , Shaw, Robert H , Stuart, Arabella S V , Greenland, Melanie , Aley, Parvinder K , Andrews, Nick J , Cameron, J Claire , Charlton, Sue , Clutterbuck, Elizabeth A , Collins, Andrea M , Dinesh, Tanya , England, Anna , Faust, Saul N , Ferreira, Daniela M , Finn, Adam , Green, Christopher A , Hallis, Bassam , Heath, Paul T , Hill, Helen , Lambe, Teresa , Lazarus, Rajeka , Libri, Vincenzo , Long, Fei , Mujadidi, Yama F , Plested, Emma L , Provstgaard-Morys, Samuel , Ramasamy, Maheshi N , Ramsay, Mary , Read, Robert C , Robinson, Hannah , Singh, Nisha , Turner, David P J , Turner, Paul J , Walker, Laura L , White, Rachel , Nguyen-Van-Tam, Jonathan S , Snape, Matthew D , Munro, Alasdair P S , Bartholomew, Jazz , Presland, Laura , Horswill, Sarah , Warren, Sarah , Varkonyi-Clifford, Sophie , Saich, Stephen , Adams, Kirsty , Ricamara, Marivic , Turner, Nicola , Yee Ting, Nicole Y , Whittley, Sarah , Rampling, Tommy , Desai, Amisha , Brown, Claire H , Qureshi, Ehsaan , Gokani, Karishma , Naker, Kush , Kellett Wright, Johanna K , Williams, Rachel L , Riaz, Tawassal , Penciu, Florentina D , Di Maso, Claudio , Howe, Elizabeth G , Vichos, Iason , Ghulam Farooq, Mujtaba , Noristani, Rabiullah , Yao, Xin L , Oldfield, Neil J , Hammersley, Daniel , Belton, Sue , Royal, Simon , San Francisco Ramos, Alberto , Hultin, Cecilia , Galiza, Eva P , Shiham, Farah , Solórzano, Carla , Sainsbury, Hannah , Davies, Kelly , Ambrose, Pauline , Hitchins, Lisa , Baker, Natalie , Leung, Stephanie , Fothergill, Ross , Godwin, Kerry , Buttigieg, Karen , Shaik, Imam , Brown, Phill , Knight, Chanice , Lall, Paminder and Allen, Lauren

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2021-09, Vol.398 (10303), p.856-869

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Use of heterologous prime-boost COVID-19 vaccine schedules could facilitate mass COVID-19 immunisation. However, we have previously reported that heterologous schedules incorporating an adenoviral vectored vaccine (ChAdOx1 nCoV-19, AstraZeneca; hereafter referred to as ChAd) and an mRNA vaccine (BNT162b2, Pfizer–BioNTech; hereafter referred to as B...

Alternative Titles

Full title

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8346248

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8346248

Other Identifiers

ISSN

0140-6736,1474-547X

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(21)01694-9

How to access this item